Beyond Fines: How Pharma CEOs Can Turn Compliance into a Competitive Advantage
Pharmaceutical companies are facing unprecedented regulatory scrutiny, with fines for non-compliance reaching billions of dollars globally. In 2023 alone, the pharmaceutical industry paid over $10 bil...